Form D — Topaz Biosciences, Inc.
0002062605-25-000001 · filed 2025-03-25
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $3,159,994
- Total sold
- $1,434,996
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Topaz Biosciences, Inc.
- CIK
- 2062605
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 1250 45th Street, Suite 320
Emeryville, CA 94608 - Phone
- 415-572-3901
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Oliver Liu · Executive OfficerEmeryville, CA Find on LinkedIn ↗
-
Caroline Hadfield · Executive OfficerEmeryville, CA Find on LinkedIn ↗
-
Jennifer Shock · Executive OfficerEmeryville, CA Find on LinkedIn ↗
-
Teresa Shock · DirectorEmeryville, CA Find on LinkedIn ↗
View original on SEC EDGAR.